Puleva Biotech sees strong growth

- Last updated on GMT

Related tags: Nutrition

Puleva Biotech, the functional foods subsidiary of Spanish food
group Ebro Puleva, recorded a 3 per cent increase in net profit in
the first nine months of the year on the back of a 50 per cent rise
in turnover to €5.34 million.

The sales growth is being driven primarly by increased demand for its functional food ingredients to the parent firm.

EBITDA grew 27 per cent to €2.7 million, said Puleva Biotech​, but it has also seen increasing costs related to investments in its plant and certain R&D projects over the nine-month period from a year earlier.

Puleva spent around €3 million on a new plant to manufacture its new probiotic strains for the dairy industry.

But earlier this month it warned that net profits were expected to decline to €1.42 million in 2004 and to €1.16 million in 2005 from the €1.89 million recorded in 2003.

An upward trend in earnings is expected to resume in 2006, when net profit is forecast at €1.7 million, said the company.

Related topics: Probiotics & prebiotics

Related news

Related products

show more

Probiotic for Children’s Health: B. subtilis DE111

Probiotic for Children’s Health: B. subtilis DE111

Deerland Probiotics & Enzymes | 01-Apr-2021 | Technical / White Paper

In a 2020 survey parents said they see digestive supplements as allies in keeping their kids healthy physically and mentally in these uncertain times;...

Kaneka DR7™ The Dynamic Probiotic for Gut & Brain

Kaneka DR7™ The Dynamic Probiotic for Gut & Brain

Kaneka Probiotics | 29-Mar-2021 | Technical / White Paper

Did you know that 95% of your body’s serotonin (the neurotransmitter that impacts mood, stress, anxiety and immunity) comes from the gut? Microbiota can...

Related suppliers

Follow us

Products

View more

Webinars